PDT Partners, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 224 filers reported holding PDL BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2015$1,820,000
+69.3%
258,702
+85.5%
0.04%
-57.9%
Q4 2014$1,075,000
-75.8%
139,465
-76.5%
0.11%
-7.8%
Q3 2014$4,433,000
+147.9%
593,499
+175.8%
0.12%
+169.8%
Q1 2014$1,788,000
-44.2%
215,206
-46.4%
0.04%
-50.6%
Q3 2013$3,202,000
+2271.9%
401,814
+2196.1%
0.09%
+2800.0%
Q2 2013$135,00017,5000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2014
NameSharesValueWeighting ↓
HAYS ADVISORY LLC 1,037,600$6,672,0000.97%
Global X Management CO LLC 2,435,411$15,660,0000.86%
Advisors Asset Management, Inc. 5,373,113$34,549,0000.47%
Gotham Asset Management, LLC 7,233,838$46,514,0000.39%
TFS CAPITAL LLC 582,438$3,745,0000.37%
LOMBARDIA CAPITAL PARTNERS LLC 1,637,611$10,530,0000.36%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 95,122$611,634,0000.33%
FIRST TRUST ADVISORS LP 17,536,793$112,762,0000.29%
Arrow Investment Advisors, LLC 214,595$1,380,0000.28%
GSA CAPITAL PARTNERS LLP 954,853$6,140,0000.24%
View complete list of PDL BIOPHARMA INC shareholders